Navigation Links
Organizational Changes at Silence Therapeutics
Date:7/17/2008

LONDON, July 17 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNAi focused biotechnology company, announces that for personal reasons, Jeffery Vick has resigned as Group CEO and left the Company.

The Board of Directors has appointed Iain Ross, currently Non-Executive Chairman, full time Chairman and Group CEO with immediate effect. Jeremy Curnock Cook, a Non-Executive Director of the Company has been appointed Senior Independent Non-Executive Director.

On behalf of the Board of Silence Therapeutics plc, Jeremy Curnock Cook said:

"Iain Ross was responsible for the financial and operational turnaround of the Company from July 2004 until July 2007, and the Silence Board of Directors is confident that under his executive leadership, significant shareholder value can be generated. Iain is an experienced business negotiator and we believe he can bring to fruition a number of deals and collaborations currently under discussion."

Iain Ross, Chairman & CEO added:

"I believe that by employing a more focused and aggressive approach, and with the continued support of a first class management team, we can achieve meaningful technical and commercial milestones over the next 12 months.

We have a unique proprietary position in the RNAi space and I am confident that this will be further strengthened in the coming months and will be the basis upon which investors and pharmaceutical partners alike will take an increasing interest in this Company.

Through current licensing agreements, products based upon the Company's AtuRNAi technology are in the clinic and we plan to submit a regulatory filing before the end of 2008 to commence clinical trials for our lead internal development compound Atu027. I intend to commence partnering discussions, following the interest that has been expressed by a number of third parties in this development program."

Notes to Editors:

About Silence Therapeut
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Edwards Lifesciences Announces Organizational Changes
3. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
4. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
5. Indevus Announces Management Changes
6. Molecular changes in brain fluid give insight into brain-damaging disease
7. Genmab A/S - Changes Board/Management/Auditors
8. GeneNews announces management changes to support commercialization of ColonSentry(TM)
9. Surface Logix Announces Executive Management Changes
10. China Sky One Medical, Inc. Changes Management Team
11. NYU Medical Center Changes Name to Honor Chairman of Board & Wife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Colo. , Jan. 23, 2015  Array BioPharma Inc. ... has reached a definitive agreement with Novartis Pharma AG ... inhibitor currently in Phase 3 development.  This agreement is conditional ... GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected ...
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces ... of office space for Shire a leading biopharmaceutical company, at ... Transwestern | RBJ,s Robert Richards , president, and ... lease for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 zFlo Motion ... pleased to announce an exciting product from a new partner. ... analysis solutions over the past 15 years, with offerings in ... recently, their 3D IMU system (inertial measurement unit), iSen, is ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
... InterMune, Inc.,(Nasdaq: ITMN ) today announced that ... present at the BMO Capital Markets 2008 Focus,on Healthcare ... 10:00 a.m. EDT., To access a live audio ... log on to the investor relations page of InterMune,s,corporate ...
... Bioheart, Inc.,(Nasdaq: BHRT ) a company ... monitor, diagnose and treat heart failure and,cardiovascular diseases, ... June 30, 2008., Recent Clinical Highlights:, ... the results of a preclinical,study involving the injection ...
... ... patients into screening completed in second LymphoStat-B(R), Phase 3 trial in systemic lupus erythematosus; completion of randomization ... expected in August 2008 -, - Initial data from Phase 2 ... third quarter 2008 ...
Cached Biology Technology:Bioheart, Inc. Announces Financial Results for Second Quarter 2008 2Bioheart, Inc. Announces Financial Results for Second Quarter 2008 3Bioheart, Inc. Announces Financial Results for Second Quarter 2008 4Bioheart, Inc. Announces Financial Results for Second Quarter 2008 5Bioheart, Inc. Announces Financial Results for Second Quarter 2008 6Bioheart, Inc. Announces Financial Results for Second Quarter 2008 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 2Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 3Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 4Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 5Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 8Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 9
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... digital media watermarking and fingerprinting markets. Watermarking aims ...
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced the ... Apple/AuthenTec TMDR92 & Sapphire - Technology Report" report ... Following the acquisition of AuthenTec in ... the iPhone 5S. It is currently the only device ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., ... a study that pinpoints fine-scale differences in genetic ancestry of ... Since immigrants first arrived more than four hundred ... served as a meeting place for peoples from different continents. ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... human world record for the most densely populated space and ... equivalent, the most species rich area on earth. The team,s ... reveal the record is contested between South America,s tropical rainforests ... of species in one space and the questions it raises ...
... he knows what was ailing Tiny Tim, the iconic character ... descriptions of both the symptoms and living conditions of 18th ... a combination of rickets and tuberculosis (TB). His findings ... of Pediatrics and Adolescent Medicine . Dr. ...
... a way to create temporary holes in the membranes of ... be published in JoVE, the Journal of Visualized Experiments ... for this method when we wanted to be able to ... on cells," said paper-author Dr. Delphine Dean. She said ...
Cached Biology News:European grasslands challenge rainforests as the most species-rich spaces on Earth 2Researchers print live cells with a standard inkjet printer 2
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... vitro diagnostic assays, all EIA/RIA plates are ... binding, high optical clarity and low background ... of the Certified Surface Chemistry Programme, which ... QA release specifications. Linkage: This CLS number ...
... clarification reagent; Ideal for clarifying many ... proteins, nucleic acids, & proteoglycans; Contains ... improves downstream processing; Utilizes a reagent ... supplied as a suspension in saline; ...
... The lyophilization stabilizer is designed to ... and for long-term storage. There ... ingredients. It is a convenient ... 7.2, and is superior to other ...
Biology Products: